Zynerba Pharmaceuticals Inc (ZYNE) Stock

DelistedNasdaq: ZYNEZynerba Pharmaceuticals, Inc.

1.30
Final close · Oct 10, 2023

ZYNE is no longer traded. Zynerba Pharmaceuticals was delisted from the Nasdaq in October 2023.

Prices on this page are historical; the last trade was October 10, 2023 at $1.30.

Zynerba Pharmaceuticals stock price history

Split-adjusted closes, 2015–2023

ZYNE final trading statistics

Final close
$1.30
Final trading day
Oct 10, 2023
Market cap at delisting
$70.12M
Shares outstanding
53.94M
Final 52-week range
$0.25 – $1.40
Avg. volume (final 3 mo.)
1,053,320
All-time high (split-adj.)
$36.49 · Aug 2015
All-time low (split-adj.)
$0.30 · May 2023
Return since IPO
-92.0%
Beta
1.19
Book value / share
$0.57
Price / book
2.26
Final 52 wk
0.251.40

Zynerba Pharmaceuticals earnings per share

Earnings per share

Zynerba Pharmaceuticals revenue & net income

RevenueNet income

Zynerba Pharmaceuticals annual financials

Fiscal yearRevenueNet incomeEPS
FY2022$0.00-$34.8M-$0.83
FY2021$0.00-$37.6M-$0.93
FY2020$0.00-$50.4M-$1.95
FY2019$0.00-$31.4M-$1.87
FY2018$86.0K-$39.9M-$2.71

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Zynerba Pharmaceuticals Inc

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania. As of October 10, 2023, Zynerba Pharmaceuticals, Inc. operates as a subsidiary of Harmony Biosciences Holdings, Inc.

Zynerba Pharmaceuticals stock FAQ

What happened to Zynerba Pharmaceuticals stock?

Zynerba Pharmaceuticals stock was delisted from the Nasdaq. Its final close was $1.30 on October 10, 2023.

Is ZYNE stock still trading?

No. ZYNE was delisted from the Nasdaq in October 2023 and no longer trades on a U.S. exchange.

What was the last price of ZYNE stock?

ZYNE closed at $1.30 on its final trading day, October 10, 2023, for a market value of about $70.12M.

What were Zynerba Pharmaceuticals's revenue and earnings in its last full fiscal year?

Zynerba Pharmaceuticals reported revenue of $0.00 and net income of -$34.8M in fiscal 2022, its last full year as a public company.

When did Zynerba Pharmaceuticals go public?

Zynerba Pharmaceuticals Inc stock began trading on August 5, 2015.

Drug Manufacturers - Specialty & Generic stocks to research

All Healthcare stocks →